Clinician perspectives on delivering medication treatment for opioid use disorder during the COVID-19 pandemic: A qualitative evaluation

Clinician perspectives on delivering medication treatment for opioid use disorder during the COVID-19 pandemic: A qualitative evaluation

This 1-hour, journal article-based CME activity reviewed a qualitative study of clinician beliefs and perceptions about the impacts of changes to the delivery of medication treatment for opioid use disorder (MOUD) during the COVID-19 pandemic, with a focus on the switch to care delivery via telemedicine. Perceived benefits and limitations of telemedicine as a care delivery modality for MOUD and beliefs about impacts on patient safety and well-being were explored. Implications for post-pandemic continuance of telemedicine in MOUD care were also discussed.

  • Provider:American Society of Addiction Medicine
  • Activity Link: https://elearning.asam.org/
  • Start Date: 2023-06-23 05:00:00
  • End Date: 2023-06-23 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
  • MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
    ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
    ABP - 1.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP)
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: Variable
  • Measured Outcome: Learner/Team Competence, Learner/Team Performance
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: Adolescent Medicine, Critical Care Medicine, General Pediatrics, General Surgery, Hospital Medicine, Internal Medicine, Medical Toxicology, Pediatric Surgery, Surgical Critical Care
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.